Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea

K Takasuna, T Hagiwara, K Watanabe, S Onose… - Cancer chemotherapy …, 2006 - Springer
Purpose: An antitumor camptothecin derivative CPT-11 has proven a broad spectrum of
solid tumor malignancy, but its severe diarrhea has often limited its more widespread use …

Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea.

K Takasuna, T Hagiwara, K Watanabe… - Cancer …, 2006 - europepmc.org
Purpose An antitumor camptothecin derivative CPT-11 has proven a broad spectrum of solid
tumor malignancy, but its severe diarrhea has often limited its more widespread use. We …

[PDF][PDF] Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea

K Takasuna, THK Watanabe, E Nagai… - Cancer Chemother …, 2006 - mhlw-grants.niph.go.jp
Purpose: An antitumor camptothecin derivative CPT-11 has proven a broad spectrum of
solid tumor malignancy, but its severe diarrhea has often limited its more widespread use …

Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea.

K Takasuna, T Hagiwara, K Watanabe… - Cancer …, 2006 - search.ebscohost.com
Abstract < bold> Purpose: </bold> An antitumor camptothecin derivative CPT-11
has proven a broad spectrum of solid tumor malignancy, but its severe diarrhea has often …

Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea

K Takasuna, T Hagiwara, K Watanabe, S Onose… - Cancer Chemotherapy …, 2006 - infona.pl
Purpose: An antitumor camptothecin derivative CPT-11 has proven a broad spectrum of
solid tumor malignancy, but its severe diarrhea has often limited its more widespread use …

Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea

K Takasuna, T Hagiwara… - Cancer …, 2006 - pubmed.ncbi.nlm.nih.gov
Purpose An antitumor camptothecin derivative CPT-11 has proven a broad spectrum of solid
tumor malignancy, but its severe diarrhea has often limited its more widespread use. We …

Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea

K Takasuna, T Hagiwara, K Watanabe… - Cancer …, 2006 - search.proquest.com
Purpose: An antitumor camptothecin derivative CPT-11 has proven a broad spectrum of
solid tumor malignancy, but its severe diarrhea has often limited its more widespread use …

[引用][C] Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea

K TAKASUNA, T HAGIWARA… - Cancer …, 2006 - pascal-francis.inist.fr
Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced
delayed diarrhea CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

[引用][C] Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea

K Takasuna, T Hagiwara, K Watanabe… - Cancer Chemotherapy …, 2006 - cir.nii.ac.jp

[引用][C] Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea

K TAKASUNA - Cancer Chemother. Pharmacol., 2006 - cir.nii.ac.jp
Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced
delayed diarrhea | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …